Publications

Variation in antiviral immunity and inflammation pathways precedes HIV-1 infection in a high-risk African cohort

Journal of Clinical Investigation

This study examined why some people are more likely than others to become infected with HIV. Researchers followed a group of individuals in Africa who were at high risk of HIV infection and looked at their immune responses before they were exposed to the virus. 

The results showed that differences in the way people’s immune systems responded and how their bodies-controlled inflammation existed even before infection. Some participants had immune patterns that might make it easier for HIV to establish infection, while others showed responses that could offer some natural protection. 

These findings suggest that individual differences in immunity and inflammation play an important role in whether a person becomes infected with HIV. Understanding these differences could help in developing better prevention strategies, vaccines, and treatments by targeting the underlying immune mechanisms that influence susceptibility. 

SANTHE is an Africa Health Research Institute (AHRI) flagship programme funded by the Science for Africa Foundation through the DELTAS Africa programme; the Gates Foundation; Gilead Sciences Inc.; and the Ragon Institute of Mass General, MIT, and Harvard.